Analysis of National Institutes of Health Funding for the COVID-19 Pandemic.
Adishesh K NarahariTaylor M HorganAnirudha S ChandrabhatlaD Chris GistParanjay D PatelMark A LantieriJeffrey M SturekClaire L DavisPatrick E H JacksonTaison D BellPublished in: Open forum infectious diseases (2024)
Evaluating the outcome of the NIH's response to the COVID-19 pandemic is of interest to the general public. The present study finds that the NIH disbursed more than $4 billion in funding to large consortiums and clinical trials to develop diagnostics, therapeutics, and vaccines. Approximately 8% of funding was used for R01 grants. Clinical trial sites were generally located in areas of high COVID-19 burden.